Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New ALS (amyotrophic lateral sclerosis) gene identified:

This article was originally published in Clinica

Executive Summary

Swedish scientists have discovered a novel gene for motor neurone disease, or amyotrophic lateral sclerosis (ALS). The gene - ITPR2 (inositol 1,4,5-triphosphate receptor 2) - was identified in "the world's most comprehensive study in the field thus far", according to the researchers, based at the Umea University. ITPR2 codes for a protein that is important for the regulation of calcium levels in the neurones. The protein is also involved in neurotransmission, and programmed cell death, or apoptosis. The team is now looking for disease-related mutations in the gene. The findings were published in an early online publication of The Lancet Neurology, on September 7.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049738

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel